Can dietitian Check-Ins prevent weight loss after head and neck cancer surgery?
NCT ID NCT03632200
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether extra nutritional counseling helps head and neck cancer patients maintain their weight after surgery. 60 adults having surgery for head and neck cancer will be split into two groups: one gets standard care, the other gets extra support from a dietitian and other specialists before and after surgery. The main goal is to see if the extra support prevents weight loss six months later.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- multidisciplinary nutritional consultation (dietitian, physiotherapist, nurse)
- What this could lead to
- If it works, this could show that extra nutritional counseling helps patients avoid weight loss after head and neck cancer surgery.
- What could go wrong
- This is a small, early-stage study (60 people) comparing two groups. The results may not apply to all patients, and the extra support may not significantly improve weight maintenance.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2019
- Expected to finish
-
Sep 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients affected by a cancer of the VADS * Man or woman of 18 and more years old * Patient benefiting from a surgery for its cancer of the VADS * Patient having signed a written consent * Patient member in a national insurance scheme Exclusion Criteria: * Patient minor * Patient benefiting from a radiotherapy * Patient participant in another research interfering on the nutritional state of the patient * Patients under guardianship or guardianship
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Head and neck cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
CHU Amiens-Picardie
RECRUITINGAmiens, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental pill HG146 put to the test against rare head and neck cancer
- Can a dental assistant keep cancer Patients' mouths healthier during radiation?
- Why do Non-Smokers get head and neck cancer? scientists probe tumor DNA
- Re-irradiation plus cetuximab targets head and neck tumors that return
- Sharper tumor maps: PET scans could tighten radiation beams
- Five days of radiation instead of weeks: a new test for head and neck cancer